First Trust Advisors LP lowered its position in PetMed Express Inc. (NASDAQ:PETS) by 73.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,362 shares of the company’s stock after selling 49,150 shares during the period. First Trust Advisors LP owned 0.09% of PetMed Express worth $326,000 as of its most recent filing with the SEC.
Other hedge funds have also modified their holdings of the company. Prudential Financial Inc. increased its position in PetMed Express by 3.4% in the first quarter. Prudential Financial Inc. now owns 48,464 shares of the company’s stock valued at $868,000 after buying an additional 1,600 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of PetMed Express by 43.6% in the first quarter. JPMorgan Chase & Co. now owns 45,047 shares of the company’s stock valued at $807,000 after buying an additional 13,670 shares during the last quarter. Landscape Capital Management L.L.C. boosted its position in shares of PetMed Express by 46.3% in the first quarter. Landscape Capital Management L.L.C. now owns 26,047 shares of the company’s stock valued at $467,000 after buying an additional 8,247 shares during the last quarter. Royce & Associates LP boosted its position in shares of PetMed Express by 33.2% in the first quarter. Royce & Associates LP now owns 401,500 shares of the company’s stock valued at $7,191,000 after buying an additional 100,000 shares during the last quarter. Finally, Uniplan Investment Counsel Inc. boosted its position in shares of PetMed Express by 0.3% in the first quarter. Uniplan Investment Counsel Inc. now owns 391,354 shares of the company’s stock valued at $7,009,000 after buying an additional 1,278 shares during the last quarter. 75.97% of the stock is owned by hedge funds and other institutional investors.
PetMed Express Inc. (NASDAQ:PETS) traded up 0.68% during midday trading on Friday, reaching $20.63. The company had a trading volume of 74,573 shares. The firm has a market capitalization of $416.31 million, a PE ratio of 19.65 and a beta of 1.07. PetMed Express Inc. has a 12 month low of $15.61 and a 12 month high of $21.16. The firm’s 50-day moving average price is $20.43 and its 200 day moving average price is $19.32.
PetMed Express (NASDAQ:PETS) last announced its quarterly earnings results on Monday, July 25th. The company reported $0.32 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.01. The company earned $72.50 million during the quarter. PetMed Express had a return on equity of 25.97% and a net margin of 9.09%. The business’s revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.29 earnings per share. Equities analysts anticipate that PetMed Express Inc. will post $1.11 earnings per share for the current fiscal year.
Several equities analysts have recently issued reports on PETS shares. Zacks Investment Research upgraded PetMed Express from a “hold” rating to a “buy” rating and set a $23.00 price objective for the company in a research note on Wednesday, July 27th. Credit Suisse Group AG reiterated a “sell” rating and issued a $13.00 price objective on shares of PetMed Express in a research note on Tuesday, August 16th.
In other PetMed Express news, insider Bruce S. Rosenbloom sold 1,500 shares of the stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $21.00, for a total transaction of $31,500.00. Following the transaction, the insider now owns 41,767 shares of the company’s stock, valued at approximately $877,107. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Ronald J. Korn sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $20.76, for a total value of $83,040.00. Following the completion of the sale, the director now directly owns 75,333 shares in the company, valued at approximately $1,563,913.08. The disclosure for this sale can be found here. 4.70% of the stock is owned by insiders.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express Inc. (NASDAQ:PETS).
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.